FindMyKOL
Clinical trialNCT02854072UnknownPhase 3Interventional

A Phase III Study to Assess the Efficacy and Safety of GV1001-Gem/Cap vs Gem/Cap in Pancreatic Cancer Patients

SponsorSamsung Pharmaceutical Co., Ltd.Enrollment148Pancreatic Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

To assess treatment of GV1001 concurrent with Gemcitabine/Capecitabine versus Gemcitabine/Capecitabine alone in locally advanced and metastatic pancreatic cancer patients.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

South Korea
  • Wonju Severance Christian Hospital

    Wŏnju, Gangwon-do, South Korea

    Recruiting
  • National Cancer Center

    Goyang-si, Gyeonggi-do, South Korea

    Recruiting
  • Jeju National University Hospital

    Jeju City, Jeju-do, South Korea

    Recruiting
  • Chonbuk National University Hospital

    Jeonju, Jeollabuk-do, South Korea

    Recruiting
  • Chungbuk National University Hospital

    Cheongju-si, North Chungcheong, South Korea

    Recruiting
  • Pusan National University Hospital

    Busan, South Korea

    Recruiting
  • Daegu Catholic University Medical Center

    Daegu, South Korea

    Recruiting
  • Konyang University Hospital

    Daejeon, South Korea

    Recruiting
  • Chonnam National University Hospital

    Gwangju, South Korea

    Recruiting
  • Gachon University Gil Medical Center

    Incheon, South Korea

    Recruiting
  • Gangnam Severance Hospital

    Seoul, South Korea

    Recruiting
  • Hanyang University Seoul Hospital

    Seoul, South Korea

    Recruiting
  • Korea University Anam Hospital

    Seoul, South Korea

    Recruiting
  • Samsung Medical Center

    Seoul, South Korea

    Recruiting
  • Seoul National University Hospital

    Seoul, South Korea

    Recruiting
  • Severance Hospital

    Seoul, South Korea

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Nov 2015
Primary completion
31 May 2018
Completion
31 May 2018
Last update posted
22 Nov 2016
Registered enrollment
148
Registry id
NCT02854072

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.